Nephrology

The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.

39th Annual Meeting and Scientific Exhibition of the American Society of Nephrology

Renin and Blood Pressure Regulation: Protecting the Kidney and the Heart

San Diego, California / November 14-19, 2006

San Diego - Inhibition of the renin-angiotensin system with either an ACE inhibitor or an angiotensin II receptor blocker (ARB) significantly attenuates the development of microalbuminuria, a marker of impending kidney and cardiovascular...

39th Annual Meeting and Scientific Exhibition of the American Society of Nephrology

Managing Bone and Mineral Metabolism Disorders in Chronic Kidney Disease

San Diego, California / November 14-19, 2006

San Diego - Treatment of end-stage renal disease is challenging if physicians are to prevent the accompanying disorders in bone and mineral metabolism. Because adynamic bone disease is associated with increased vascular calcification risk,...

79th Scientific Sessions of the American Heart Association

Pre-Emptive Strike: Targeting the RAS at Point of Activation

Chicago, Illinois / November 12-15, 2006

Direct renin inhibitors (DRIs) have the potential to write a new chapter in the story of cardiovascular and renal protection. DRIs target the same pathogenic pathway as ACE inhibitors and angiotensin receptor blockers (ARBs) but at a much...

Transcatheter Cardiovascular Therapeutics 2006

Reviewing the Scientific and Clinical Landscape of Contrast-Induced Nephropathy

Washington, DC / October 22-27, 2006

INTRODUCTION Despite a multitude of advances in radiographic and angiographic techniques in recent years, contrast-induced nephropathy (CIN) continues to pose technologic challenges and clinical problems. Modern imaging modalities rely...

31st Congress of the European Society for Medical Oncology

Expanding the Attack on Kidney Cancer with Multikinase Inhibitors

Istanbul, Turkey / September 29-October 3, 2006

Istanbul – A considerable proportion of patients with renal cell carcinoma (RCC) develop metastasis and long-term survival is low for those with advanced disease. Although the cytokines interferon-alpha (IFN-a) and interleukin-2 (IL-2) have...

World Congress of Cardiology 2006

Direct Renin Inhibition: Upstream blocking of the Renin-Angiotensin System in Hypertension

Barcelona, Spain / September 2-6, 2006

INTRODUCTION In Canada, data from the 1990s indicated that approximately 17% of hypertensive patients had their blood pressure (BP) adequately controlled, ahead of BP control rates in Europe but behind US rates. However, we know that...

43rd European Renal Association/European Dialysis and Transplant Association Congress

Setting the Stage for Improved Chronic Kidney Disease Outcomes

Glasgow, United Kingdom / July 15-18, 2006

Glasgow - The annual mortality rate for patients on dialysis in Canada is approximately 15%. It is now known that treating chronic kidney disease patients on dialysis with calcium-based phosphate binders can lead to cardiac calcification....

43rd Congress of the European Renal Association/European Dialysis and Transplant Association

Controlling Phosphorus Levels and Improving Compliance in Dialysis Patients

Glasgow, United Kingdom / July 15-18, 2006

Glasgow - When undergoing hemodialysis, almost all patients develop elevated serum phosphorus levels and require a phosphate-binding agent to keep levels under control. While both calcium-containing phosphate binders and sevelamer, a...

42nd Annual Meeting of the American Society of Clinical Oncology

Targeted Therapy: A Treatment Advance in Renal Cell Carcinoma

Atlanta, Georgia / June 2-6, 2006

Atlanta - For the past two decades, the treatment of advanced renal cell carcinoma has been limited to two cytokines: interferon alpha (IFNa) and interleukin-2 (IL-2). IFNa is associated with an 11% response rate, while IL-2 has a response...

National Kidney Foundation 2006 Spring Clinical Meetings

Focus on Improving Dialysis Treatment and Updated K/DOQI Guidelines

Chicago, Illinois / April 19-23, 2006

Chicago - The National Kidney Foundation’s Kidney Disease Outcomes Quality Initiative (K/DOQI) Vascular Access Work Group reviewed literature published between August 2000 and late summer 2005 in order to update previous K/DOQI guidelines...

PAGE 5 OF 6   1 2 3 4 5 6